Zonisamide changes unilateral cortical excitability in focal epilepsy patients

Journal of Clinical Neurology (Korea)

Volumn 6, Issue 4, 2010, Pages 189-195

  Joo, Eun Yeon ^a   Kim, Hye Jung ^a   Lim, Yang Hee ^a   Ji, Ki Hwan ^a   Hong, Seung Bong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cortical excitability; Focal epilepsy; Transcranial magnetic stimulation; Zonisamide

Indexed keywords

EID: 78651477402     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2010.6.4.189     Document Type: Article

References (43)

1. Joo EY, Hong SB, Han HJ, Tae WS, Kim JH, Han SJ, et al. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain 2005;128:1802-1810.
2. Lee HW, Hong SB, Tae WS. Opposite ictal perfusion patterns of subtr-acted SPECT. Hyperperfusion and hypoperfusion. Brain 2000;123: 2150-2159.
3. Luders HO, Engle J, Munari C. General principles. In: Engel J. Surgical Treatment of the Epilepsies. New York: Raven Press, 1993;137-153.
4. Tae WS, Joo EY, Kim JH, Han SJ, Suh YL, Kim BT, et al. Cerebral perfusion changes in mesial temporal lobe epilepsy: SPM analysis of ictal and interictal SPECT. Neuroimage 2005;24:101-110.
5. Manganotti P, Bongiovanni LG, Zanette G, Turazzini M, Fiaschi A. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 1999;40:316-321.
6. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996; 496:873-881.
7. Hallett M, Chokroverty S. Magnetic Stimulation in Clinical Neurophysiology. Philadelphia: Elsevier, 2005.
8. Delvaux V, Alagona G, Gérard P, De Pasqua V, Delwaide PJ, Maertens de Noordhout A. Reduced excitability of the motor cortex in untreated patients with de novo idiopathic "grand mal" seizures. J Neurol Neurosurg Psychiatry 2001;71:772-776.
9. Reutens DC, Berkovic SF, Macdonell RA, Bladin PF. Magnetic stimulation of the brain in generalized epilepsy: reversal of cortical hyperexcitability by anticonvulsants. Ann Neurol 1993;34:351-355.
10. Werhahn KJ, Lieber J, Classen J, Noachtar S. Motor cortex excitability in patients with focal epilepsy. Epilepsy Res 2000;41:179-189.
11. Badawy RA, Curatolo JM, Newton M, Berkovic SF, Macdonell RA. Changes in cortical excitability differentiate generalized and focal epilepsy. Ann Neurol 2007;61:324-331.
12. Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C. Dose-dependent safety and efficacy of zonisamide: a randomized, dou-ble-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005;46:31-41.
13. Faught E, Ayala R, Montouris GG, Leppik IE; Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-1779.
14. Park SP, Kim SY, Hwang YH, Lee HW, Suh CK, Kwon SH. Long-term efficacy and safety of zonisamide monotherapy in epilepsy patients. J Clin Neurol 2007;3:175-180.
15. Sackellares JC, Ramsay RE, Wilder BJ, Browne TR 3rd, Shellenberger MK. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004;45:610-617.
16. Sobieszek G, Borowicz KK, Kimber-Trojnar Z, Małtek R, Piskorska B, Czuczwar SJ. Zonisamide: a new antiepileptic drug. Pol J Pharmacol 2003;55:683-689.
17. Leppik IE. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 2004;13 Suppl 1:S5-9; discussion S10.
18. Joo EY, Kim SH, Seo DW, Hong SB. Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy. Clin Neurophysiol 2008;119:1385-1392.
19. Eisai Pharmaceuticals Inc. Zonegran Zonisamide Capsules Prescribing Information. Teaneck, NJ: Eisai Pharmaceuticals Inc., 2004.
20. Tergau F, Wanschura V, Canelo M, Wischer S, Wassermann EM, Ziemann U, et al. Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation. Exp Brain Res 1999; 124:447-454.
21. Ziemann U, Chen R, Cohen LG, Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998;51:1320- 1324.
22. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993; 471:501-519.
23. Reis J, Tergau F, Hamer HM, Müller HH, Knake S, Fritsch B, et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 2002;43:1149-1156.
24. Ito T, Yamaguchi T, Miyazaki H, Sekine Y, Shimizu M, Ishida S, et al. Pharmacokinetic studies of AD-810, a new antiepileptic compound. Phase I trials. Arzneimittelforschung 1982;32:1581-1586.
25. Taylor CP, McLean JR, Bockbrader HN, Budannan RA, Xarasaua T, Meyazaki M, et al. Zonisamide (AD-810, CI-912). In: Meldrum BS, Porter RJ. New Anticonvulsant Drugs. London: John Libbey, 1986;277-294.
26. Sohn YH, Kaelin-Lang A, Jung HY, Hallett M. Effect of levetiracetam on human corticospinal excitability. Neurology 2001;57:858-863.
27. Takano K, Tanaka T, Fujita T, Nakai H, Yonemasu Y. Zonisamide: electrophysiological and metabolic changes in kainic acid-induced limbic seizures in rats. Epilepsia 1995;36:644-648.
28. Akaike K, Tanaka S, Tojo H, Fukumoto S, Imamura S, Takigawa M. Regional accumulation of 14C-zonisamide in rat brain during kainic acid-induced limbic seizures. Can J Neurol Sci 2001;28:341-345.
29. Futatsugi Y, Riviello JJ Jr. Mechanisms of generalized absence epilepsy. Brain Dev 1998;20:75-79.
30. Kim D, Song I, Keum S, Lee T, Jeong MJ, Kim SS, et al. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron 2001; 31:35-45.
31. Kito M, Maehara M, Watanabe K. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 1996;5:115-119.
32. Suzuki S, Kawakami K, Nishimura S, Watanabe Y, Yagi K, Seino M, et al. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 1992;12:21-27.
33. Marinas A, Villanueva V, Giráldez BG, Molins A, Salas-Puig J, Serratosa JM. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy. Epileptic Disord 2009;11:61-66.
34. Szaflarski JP. Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy. Epilepsy Behav 2004;5:1024-1026.
35. Reutens DC, Berkovic SF. Increased cortical excitability in generalised epilepsy demonstrated with transcranial magnetic stimulation. Lancet 1992;339:362-363.
36. Macdonell RA, King MA, Newton MR, Curatolo JM, Reutens DC, Ber-kovic SF. Prolonged cortical silent period after transcranial magnetic stimulation in generalized epilepsy. Neurology 2001;57:706-708.
37. Manganotti P, Zanette G. Contribution of motor cortex in generation of evoked spikes in patients with benign rolandic epilepsy. Clin Neurophysiol 2000;111:964-974.
38. Gianelli M, Cantello R, Civardi C, Naldi P, Bettucci D, Schiavella MP, et al. Idiopathic generalized epilepsy: magnetic stimulation of motor cortex time-locked and unlocked to 3-Hz spike-and-wave discharges. Epilepsia 1994;35:53-60.
39. Chen R, Samii A, Caños M, Wassermann EM, Hallett M. Effects of phenytoin on cortical excitability in humans. Neurology 1997;49:881-883.
40. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996;40:367-378.
41. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996;109: 127-135.
42. Inghilleri M, Conte A, Frasca V, Curra' A, Gilio F, Manfredi M, et al. Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation. Exp Brain Res 2004;154:488-493.
43. Lee HW, Seo HJ, Cohen LG, Bagic A, Theodore WH. Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal. Clin Neurophysiol 2005;116:1105-1112.